Bio-Rad Laboratories, Inc. (BIO) vs Encompass Health Corporation (EHC)
A side-by-side comparison of Bio-Rad Laboratories, Inc. and Encompass Health Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 27, 2026. Differences are shown without an overall score or investment verdict.
BIO
Bio-Rad Laboratories, Inc.
$389.94HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT
EHC
Encompass Health Corporation
$119.57HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT
Total return — BIO vs EHC
growth of $100 · dividends reinvested · last 10yBIO +156.3% (+9.9%/yr)EHC +329.5% (+15.7%/yr)EHC compounded faster over this window
BIO EHC
BIO vs EHC: by the numbers
- •EHC is the larger company ($11.86B vs $10.50B market cap).
- •EHC trades at the lower trailing earnings multiple (19.47 vs 47.11 P/E), one valuation lens rather than an overall verdict.
- •EHC converts more revenue to profit (10.01% vs 8.59% net margin).
- •EHC grew revenue faster over the past five years (4.81% vs 0.29% CAGR).
- •EHC pays a dividend (0.64% yield), while BIO has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | BIO | EHC |
|---|---|---|
| P/E ratio | 47.11 | 19.47 |
| Forward P/E | 40.31 | 19.56 |
| P/S ratio | 4.02 | 1.93 |
| P/B ratio | 1.45 | 4.60 |
| EV / EBITDA | 29.04 | 10.04 |
| FCF yield | 3.39% | 3.46% |
Profitability
| Metric | BIO | EHC |
|---|---|---|
| Gross margin | 51.90% | 95.71% |
| Operating margin | 9.08% | 18.00% |
| Net margin | 8.59% | 10.01% |
| ROE | 3.10% | 23.91% |
| ROIC | 1.54% | 13.42% |
Dividends
| Metric | BIO | EHC |
|---|---|---|
| Dividend yield | N/A | 0.64% |
| Payout ratio | N/A | 13.52% |
Growth (annualized)
| Metric | BIO | EHC |
|---|---|---|
| Revenue CAGR (5Y) | 0.29% | 4.81% |
| EPS CAGR (5Y) | -26.27% | 14.39% |
| FCF CAGR (5Y) | -9.65% | 0.28% |
| Total return CAGR (5Y) | -13.40% | 15.33% |
Frequently asked
- Which has the lower trailing P/E, BIO or EHC?
- EHC has the lower trailing P/E: BIO trades at 47.11 and EHC at 19.47. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, BIO or EHC?
- Over the past five years, EHC grew revenue faster — BIO at a 0.29% CAGR versus EHC at 4.81%.
- Does BIO or EHC pay a bigger dividend?
- EHC pays a dividend (0.64% yield), while BIO has no payments in the available dividend history.
- Is BIO or EHC more profitable?
- EHC runs the higher net margin — BIO at 8.59% versus EHC at 10.01%.
- How have BIO and EHC total returns compared?
- Over the past 10 years, BIO delivered 9.90% and EHC delivered 15.69% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bio-Rad Laboratories P/E ratioEncompass Health P/E ratioEncompass Health dividend yieldBio-Rad Laboratories ROEEncompass Health ROEBio-Rad Laboratories operating marginEncompass Health operating marginBio-Rad Laboratories revenue growthEncompass Health revenue growthBio-Rad Laboratories free cash flowEncompass Health free cash flow
Bio-Rad Laboratories & Encompass Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 27, 2026.